January 09, 2026

Clinical Posters From JADPRO Live 2025

Explore how a structured Advanced Practice Provider initiative is transforming patient care in oncology through clinical decision pathways, improving outcomes, and empowering a multidisciplinary approach.

JADPRO

January 09, 2026

Flipped Nivolumab/Ipilimumab Dosing Improves Responses, Survival, and Safety in Advanced Melanoma

The flipped dose for nivolumab 3 mg/kg and ipilimumab 1 mg/kg led to improved response rates and survival findings as well as lower severe immune-related toxicities compared with the standard dose of ...

The ASCO Post

January 09, 2026

A Rare Case of Acute Hemolysis After Rasburicase Infusion

A case study highlights the critical need for awareness of G6PD deficiency in CLL patients on venetoclax, following a rare hemolytic reaction to rasburicase.

JADPRO

January 09, 2026

Integrative Oncology Models of Care: Practice Patterns From NCCN Member Institutions

Integrative oncology is gaining traction as patients increasingly seek complementary therapies to enhance their cancer care and quality of life.

JADPRO

January 08, 2026

Cancer Treatment: When Should Doctors Change Course?

A Keck Medicine of USC hematologist-oncologist discusses signs that a different line of cancer treatment is needed.

Keck Medicine of USC

January 07, 2026

Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction

Investigators have developed and tested a hybrid reading strategy for screening mammography images with artificial intelligence (AI) that includes reads from radiologists and a stand-alone AI interpre...

The ASCO Post

January 06, 2026

IMvigor011 Subgroup Analysis: Role of ctDNA in Guiding Adjuvant Treatment for Muscle-Invasive Bladder Cancer

Circulating tumor DNA (ctDNA) status after radical cystectomy may be able to guide adjuvant treatment decisions for patients with muscle-invasive bladder cancer, according to phase III data.

The ASCO Post

January 06, 2026

AI Tops Density in Predicting Breast Cancer Risk

An image-only artificial intelligence (AI) model for predicting the 5-year risk of breast cancer provided stronger and more precise risk stratification than breast density assessment, according to a n...

The ASCO Post

January 06, 2026

Validation of Pathology-AI Integration Tool for Risk Stratification in Locally Advanced Colon Cancer Without Chemotherapy

The Combined Analysis of Pathology and Artificial Intelligence (AI; CAPAI) model effectively stratified patients with colon cancer into distinct prognostic groups, identifying nearly half as low-risk,...

The ASCO Post